Subscribe to My Feed

Tell a Friend

  • Polls

    How Is My Site? / ¿Cómo es mi sitio web?

    View Results

    Loading ... Loading ...
  • Recent Comments:

  • « | Home | »

    MERCOSUR Adopts Guidelines on Promotion, Advertising & Marketing of Pharmaceuticals

    By Keith R | December 30, 2008

    Topics: Advertising/Promotion, Health Issues, Pharmaceutical Issues | No Comments »

    1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)

    I’ve said here many times that Latin American and Caribbean (LAC) nations tend to take seriously the recommendations, guidelines and other soft norms of the World Health Organization (WHO) on any issue involving public health and/or the environment, and I’ve tried to provide a few examples where WHO work has translated into national laws and norms.

    At the end of November the Common Market of Southern Cone, better known as MERCOSUR or MERCOSUL, provided yet another concrete example, this time involving the marketing of pharmaceuticals.  [Companies facing calls for WHO action on advertising food and beverages to children, take notes!]  This new MERCOSUR rule will affect the pharmaceutical market in Argentina, Brazil, Paraguay and Uruguay, as well as Venezuela once ratification of its membership agreement is completed (although the impact may be felt less in Brazil, whcih just revised its own rules on this question).

    MERCOSUR’s Common Market Group (GMC) adopted a binding resolution on MERCOSUR Guidelines for promotion, advertising and marketing of medicines that is explicitly based on WHO’s Ethical Guidelines for Medicinal Drug Promotion.  The MERCOSUR guidelines call for:

    Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

    Subscribe to My Comments Feed

    Leave a Reply